Panagora Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Panagora Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.68M	Buy	+443,647	New	+$6.08M	0.02%	375
2022 Q3	–	Sell	-165,694	Closed	-$527K	–	1433
2022 Q2	$527K	Hold	165,694	–	–	﹤0.01%	1147
2022 Q1	$691K	Buy	165,694 +86,613	+110%	+$384K	﹤0.01%	1095
2021 Q4	$379K	Sell	79,081 -64,985	-45%	-$324K	﹤0.01%	1311
2021 Q3	$769K	Hold	144,066	–	–	﹤0.01%	1092
2021 Q2	$738K	Sell	144,066 -31,795	-18%	-$181K	﹤0.01%	1154
2021 Q1	$1.18M	Buy	+175,861	New	+$975K	0.01%	949
2020 Q2	–	Sell	-106,783	Closed	-$372K	–	2560
2020 Q1	$372K	Sell	106,783 -146,548	-58%	-$621K	﹤0.01%	1242
2019 Q4	$1.22M	Buy	+253,331	New	+$881K	0.01%	981
2018 Q4	–	Sell	-4,716	Closed	-$105K	–	2453
2018 Q3	$105K	Hold	4,716	–	–	﹤0.01%	1844
2018 Q2	$77K	Buy	+4,716	New	+$82.8K	﹤0.01%	1921

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Panagora Asset Management's AMRX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 443,647 shares worth $7.68M. The stake represents 0.02% of the portfolio and ranks #375 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in AMRX as recently as Q2 2022.

Panagora Asset Management first reported a position in AMRX in Q2 2018 and has held it in 11 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Panagora Asset Management held 443,647 shares of Amneal Pharmaceuticals worth $7.68M as of Q2 2026.
Amneal Pharmaceuticals was a new Panagora Asset Management position in Q2 2026.
Amneal Pharmaceuticals made up 0.02% of Panagora Asset Management's portfolio in Q2 2026, its #375 holding.
Panagora Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 11 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.